Sentence examples for trial data have demonstrated from inspiring English sources

In conclusion, the evidence suggests a role for fish oil (eicosapentaenoic acid, docosahexaenoic acid) or fish in secondary prevention because recent clinical trial data have demonstrated a significant reduction in total mortality, coronary heart disease death, and sudden death.

Previous randomized controlled trial data have demonstrated the efficacy of audit and feedback.

In addition to the prospective studies, randomized trial data have demonstrated an effect of aspirin on cancer recurrence.

Clinical trial data have demonstrated that varenicline has the ability to decrease cravings and withdrawal symptoms, and lessen positive reinforcement associated with smoking.

More recently, clinical trial data have demonstrated that reduction of hs-CRP is associated with marked improvements in CVD outcomes (4) and that high-intensity, preferably mixed (aerobic and resistance) exercise training, in addition to daytime physical activity (PA), is required for achieving a significant anti-inflammatory effect in subjects with type 2 diabetes (5).

They questioned the validity of the boxed warning in large part because no definitive human clinical trial data has demonstrated an increased risk of malignancy with TCI exposure.

Randomised trial data has demonstrated survival benefits using antifolates (namely pemetrexed or raltitrexed) in combination with platinum-based cytotoxics (cisplatin or carboplatin), adding around 2 months of overall survival and reducing time to progression (Vogelzang et al, 2003).

Over the last 5 years, clinical trials data has demonstrated an increasing role for raltegravir in the management of both treatment-experienced and treatment-naïve HIV-1-infected patients.

Randomized trial and registry data have demonstrated the safety and efficacy of TAVR in such patients.

Although several cardiovascular safety issues have been raised since their clinical introduction, the results of recent clinical trials and clinical pharmacologic surveillance data have demonstrated no increase in myocardial infarction rates in patients taking these agents compared with the expected rates in age-matched populations (21, 22).

However, polling data has demonstrated that Latinos and African Americans are willing to participate in these trials.